Table I.
Characteristic | Value | % |
---|---|---|
Age (years) | ||
Median | 70 | – |
Range | 44–86 | – |
Gender, n | ||
Male | 77 | 71.3 |
Female | 31 | 28.7 |
Tumor invasion, n | ||
T1 | 8 | 7.4 |
T2 | 19 | 17.6 |
T3 | 31 | 28.7 |
T4 | 50 | 46.3 |
Lymph node metastasis, n | ||
Positive | 78 | 72.2 |
Negative | 30 | 27.8 |
Lymphovascular invasion, n | ||
Positive | 92 | 85.2 |
Negative | 16 | 14.8 |
Vascular invasion, n | ||
Positive | 79 | 73.1 |
Negative | 29 | 26.9 |
Histology, n | ||
Intestinal | 48 | 44.4 |
Diffuse | 60 | 55.6 |
Preoperative chemotherapy, n | ||
Administered | 19 | 17.6 |
Not administered | 89 | 82.4 |
Postoperative chemotherapy, n | ||
Administered | 61 | 56.5 |
Not administered | 47 | 43.5 |
UICC stage, n | ||
I | 29 | 26.9 |
II | 31 | 28.7 |
III | 17 | 15.7 |
IV | 31 | 28.7 |
UICC, Union for International Cancer Control.